Share: Facebook Twitter LinkedIn
Activity Provided By:

i3 Health

Video Viewpoint Strategy Session: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer 

Access Activity

Overview / Abstract:

Learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and Jennifer Filipi, MSN, FNP-C, Massachusetts General Hospital. Start the activity now!


There are an estimated 13,800 new cases of cervical cancer in the United States each year, and 4,290 people die of the disease (ACS, 2020). Deaths have declined during the past few decades due to screening and heightened awareness, yet this malignancy continues to be a global health concern and is considered an epidemic in parts of the world. A significant proportion of patients develop advanced disease, which is rarely curable with available therapies, and treatment is often limited to palliative care (NCCN, 2020). The 5-year overall survival rate is 56% for women with regional disease and 17% for those with distant disease; amongst black women, the prognosis is worse (Siegel et al, 2020).


Oncologists, gynecologists, physician assistants, nurse practitioners, oncology nurses, and other health care professionals involved in the treatment of patients with cervical cancer.


Upon completion of this activity, participants should be able to:

Evaluate the utility of biomarker testing in the management of advanced cervical cancer
Assess recent clinical trial data on the use of novel immunotherapies in the treatment of recurrent and metastatic cervical cancer
Evaluate strategies to manage adverse events associated with novel immunotherapies for cervical cancer


Aug 24, 2022


Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME


Online, Webinar / Webcast / Video

Credits / Hours

0.75 CME | 0.75 NCPD | MOC | ILNA



Presenters / Authors / Faculty

Bradley J. Monk, MD, FACS, FACOG
Professor of Gynecologic Oncology
University of Arizona College of Medicine

Jennifer Filipi, MSN, FNP-C
Nurse Practitioner
Massachusetts General Hospital

Sponsors / Supporters / Grant Providers

This activity is supported by educational funding provided by Merck.

Keywords / Search Terms

i3 Health i3 Health, cervical cancer, metastatic cervical cancer, cancer, gyncology, oncology, NCPD, CE, free NCPD, free CE, ILNA points, free ILNA points, i3 Health, online NCPD Free CE CME Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map